Jeff Yass’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
Jeff Yass's DSGN Position: Q3 2026 in Review
Jeff Yass increased its Design Therapeutics (DSGN) stake by 144% in Q3 2026, buying an estimated $311K and bringing the position to 38,149 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #9854.
Jeff Yass first reported a position in DSGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.75M in Q1 2023. 140 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Jeff Yass held 38,149 shares of Design Therapeutics worth $480K as of Q3 2026.
- Jeff Yass bought 22,499 Design Therapeutics shares in Q3 2026, an estimated $311K.
- Design Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9854 holding.
- Jeff Yass first reported a position in Design Therapeutics in Q2 2022 and has held it in 16 quarters since.
- Jeff Yass's Design Therapeutics position peaked at $1.75M in Q1 2023.
- 140 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.